Phase II Evaluation of AHCC for the Eradication of HPV Infections

NACompletedINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

April 30, 2015

Primary Completion Date

November 30, 2019

Study Completion Date

November 30, 2019

Conditions

Human Papilloma VirusDysplasiaCIN1CIN2

Interventions

DIETARY_SUPPLEMENT

AHCC 3 grams once a day

AHCC supplementation x 6 months with Placebo x 6 months

OTHER

Placebo

Placebo supplementation x 12 months

Trial Locations (1)

UTHealth Medical School at Houston, Houston

All Listed Sponsors

lead

The University of Texas Health Science Center, Houston

OTHER

NCT02405533 - Phase II Evaluation of AHCC for the Eradication of HPV Infections | Biotech Hunter | Biotech Hunter